SaifM. (2013). U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer. JOP. Journal of the Pancreas, 14(6), 686-688. https://doi.org/10.6092/1590-8577/2028